Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cipla
Argus Health
Citi
McKesson
US Army

Generated: September 19, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,486,526

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,486,526
Title:Treatment for diabetes in patients inappropriate for metformin therapy
Abstract: The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients for whom metformin therapy is inappropriate due to intolerability or contraindication against metformin.
Inventor(s): Dugi; Klaus (Dresden, DE), Graefe-Mody; Eva Ulrike (Ingelheim am Rhein, DE), Harper; Ruth (Reading, GB), Woerle; Hans-Juergen (Munich, DE)
Assignee: Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
Application Number:14/294,630
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,486,526
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 9,486,526

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Boehringer Ingelheim TRADJENTA linagliptin TABLET;ORAL 201280-001 May 2, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS WITH SEVERE CHRONIC RENAL IMPAIRMENT AND WHO ARE INELIGIBLE FOR METFORMIN THERAPY BY ADMINISTERING LINAGLIPTIN ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 9,486,526

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
08161989Aug 7, 2008
08166827Oct 16, 2008

International Family Members for US Patent 9,486,526

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 072920 ➤ Sign Up
Australia 2009279085 ➤ Sign Up
Canada 2732803 ➤ Sign Up
Chile 2011000259 ➤ Sign Up
China 102105145 ➤ Sign Up
China 103550219 ➤ Sign Up
China 105126105 ➤ Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cantor Fitzgerald
Cipla
Express Scripts
Fuji
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.